Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 4/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TET3 | O43151 | 1/20 | 0.30 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1897831 | 0.87 | ALDH1A1 (0.68) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| SCHEMBL2018843 | 0.87 | ALDH1A1 (0.68) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| Methacrylic Acid SCHEMBL3676604 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| Methacrylic Acid SCHEMBL17961024 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| SCHEMBL27809702 | 0.84 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| Itaconate SCHEMBL15419775 | 0.83 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBEGLN1ALOX15 | |
| Methacrylic Acid SCHEMBL28070047 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| SCHEMBL667786 | 0.83 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBEGLN1ALOX15 | |
| Methacrylic Acid SCHEMBL10387701 | 0.83 | ALDH1A1 (0.68) | ALDH1A1TSHRTHRBTGFBR1EGLN1 | |
| Methacrylic Acid SCHEMBL1291895 | 0.83 | ALDH1A1 (0.68) | ALDH1A1TSHRTHRBTGFBR1EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9637729-B2 | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides | UAS LABORATORIES LLC (US) | 2017-05-02 | — | — | US | claimed |
| EP-3067056-A1 | BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE | UAS Laboratories LLC (US) | 2016-09-14 | — | — | EP | claimed |
| EP-2419114-B1 | BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE | UAS LAB LLC (US) | 2016-04-20 | — | — | EP | claimed |
| US-20150166975-A1 | Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides | UAS LABORATORIES LLC (US) | 2015-06-18 | — | — | US | claimed |
| US-8932578-B2 | Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides | UAS LABORATORIES LLC (US) | 2015-01-13 | — | — | US | claimed |
| EP-2419114-A1 | BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE | Micropharma Limited (CA) | 2012-02-22 | — | — | EP | claimed |
| JP-2011525116-A | — | — | 2011-09-15 | — | — | JP | claimed |
| US-7939061-B2 | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides | MICROPHARMA LIMITED (CA) | 2011-05-10 | — | — | US | claimed |
| EP-2300604-A1 | NITRIC OXIDE COMPOSITIONS AND DEVICES AND METHODS FOR COSMESIS | Micropharma Limited (CA) | 2011-03-30 | — | — | EP | claimed |
| EP-2300603-A1 | NITRIC OXIDE DEVICE AND METHOD FOR WOUND HEALING, TREATMENT OF DERMATOLOGICAL DISORDERS AND MICROBIAL INFECTIONS | Micropharma Limited (CA) | 2011-03-30 | — | — | EP | claimed |
| WO-2010124387-A1 | BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE | MICROPHARMA LIMITED (CA) | 2010-11-04 | — | — | WO | claimed |
| US-20100074933-A1 | Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides | CHR. HANSEN A/S (DK) | 2010-03-25 | — | — | US | claimed |
| WO-2009155689-A1 | NITRIC OXIDE DEVICE AND METHOD FOR WOUND HEALING, TREATMENT OF DERMATOLOGICAL DISORDERS AND MICROBIAL INFECTIONS | MICROPHARMA LIMITED (CA) | 2009-12-30 | — | — | WO | claimed |
| WO-2009155690-A1 | NITRIC OXIDE COMPOSITIONS AND DEVICES AND METHODS FOR COSMESIS | MICROPHARMA LIMITED (CA) | 2009-12-30 | — | — | WO | claimed |
| WO-2024108164-A1 | ENZYMATICALLY PRODUCED BIOPESTICIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-116794759-A | Optical laminate and image display device | 富士胶片株式会社 | 2023-09-22 | — | — | CN | disclosed |
| US-20230090705-A1 | RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF | SYNLOGIC OPERATING COMPANY, INC. | 2023-03-23 | — | — | US | disclosed |
| US-20070116671-A1 | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides | CHR. HANSEN A/S (DK) | 2007-05-24 | — | — | US | disclosed |
| EP-1639108-A2 | CELL AND ENZYME COMPOSITIONS FOR MODULATING BILE ACIDS, CHOLESTEROL AND TRIGLYCERIDES | McGILL UNIVERSITY (CA) | 2006-03-29 | — | — | EP | disclosed |
| WO-2004076657-A2 | CELL AND ENZYME COMPOSITIONS FOR MODULATING BILE ACIDS, CHOLESTEROL AND TRIGLYCERIDES | MCGILL UNIVERSITY (CA) | 2004-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100074933-A1 | Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides | CEL, CETP, PNLIP | ALDH1A1 1394/4885TSHR 1287/4885THRB 887/4885 |
| US-20070116671-A1 | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides | CEL, CETP, PNLIP | ALDH1A1 1394/4885TSHR 1287/4885THRB 887/4885 |
| US-20150166975-A1 | Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides | CEL, CETP, PNLIP | ALDH1A1 1394/4885TSHR 1287/4885THRB 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.